Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultra-short-term Treatment for Anemia in Scoliosis Surgery
NCT04343170Completed
- Sponsor
- Tanta University
- Start
- Sep 2023
- Primary completion
- Sep 2024
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, double-blind trial of ferric carboxymaltose, epoetin alfa, cyanocobalamin and folic acid in anemia and iron deficiency anemia (IDA) (2 arms), sponsored by Tanta University. Primary endpoint: Percentage of patients not requiring blood transfusion at 7 days. Started Sep 2023; status: completed.
02
Drugs
ferric carboxymaltoseepoetin alfacyanocobalaminfolic acid
03
Conditions
anemiairon deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT04343170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04343170.